BEDMINSTER, NJ and DUBLIN, IRELAND / ACCESSWIRE / November 2, 2016 / Amarin Corporation plc (AMRN) will host a conference call and live webcast to discuss the results of the third quarter 2016, to be held Thursday, November 3, 2016 at 7:30 AM Eastern Time.
Live Event Information
To participate, connect approximately 5 to 10 minutes before the beginning of the event
- Date, Time: November 3, 2016 at 7:30 AM ET
- Toll Free: 877-407-8033
- International: 201-689-8033
- Live Webcast: http://www.investorcalendar.com/IC/CEPage.asp?ID=175436 or www.amarincorp.com
The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on November 17, 2016.
- Toll Free: 1-877-660-6853
- International: 1-201-612-7415
- Replay ID#: 13649077
- Webcast: www.investorcalendar.com or www.amarincorp.com
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes a commitment to an ongoing outcomes study. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is a highly-pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information about Amarin visit www.amarincorp.com.
SOURCE: Investor Calendar